Skip to content

Author

Liang Xiong

We have 1 of 6 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Bispecific ANXA2/CD147 CAR-T cell therapy for osteosarcoma

A novel bispecific ANXA2/CD147 CAR-T cell was developed to provide an experimental basis for improving the therapeutic outcome of osteosarcoma and generated a bispecific ANXA2/CD147 CAR-T cell with robust antitumor activity, providing a promising new strategy for the immunotherapy of osteosarcoma.

Hai-Jun Tang, Wei Dai, Dan-Ting Xiao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.